Javascript must be enabled to use this form.

View Profile	Home Browse Faculty Facility Research Consortia Training Grants Courses Search Support About rSp Help and FAQ's Contact Us	GCC Home
Faculty Profile Last Modified Time: 08:13:57 AM Thu, 19 Jul 2018   Contact Information Mark D Pagel Associated Profiles  Professor and Deputy Chair, Cancer Systems Imaging, UT MD Anderson Cancer Center   MDA 3SCR4.3642, Room No.: Unit 1907    mdpagel@mdanderson.org     713.205.8515    Web Link    Lab Webpage    Contrast Media, Magnetic Resonance Imaging, Neoplasms, Molecular Imaging, Magnetic Resonance, Imaging Techniques, Enzyme Activity    Associated Profiles Professional Preparation Research and Expertise Affiliations Appointments  Professional Preparation  Degree Major Institution Year  PhD Chemistry University of California 1993  BA Biology and Chemistry Washington University 1988  Research and Expertise Research Interests   The Contrast Agent Molecular Engineering Laboratory (CAMEL) develops molecular imaging methods that evaluate biomarkers of the tumor microenvironment, including extracellular acidosis, hypoxia, enzyme activity and redox state. We specialize in the synthesis and characterization of chemical contrast agents for magnetic resonance imaging (MRI), positron emission tomography (PET), PET/MRI, and MultiSpectral Optoacoustic Tomography. We develop advanced acquisition and analysis methods that are tailored for each contrast agent and tumor biomarker. We apply our imaging methods to evaluate the early response to treatment in tumor models, and to improve molecular imaging assessments of patients who have cancer or who are undergoing cancer treatment. CAMEL is a highly multidisciplinary research environment that encourages collaborations with colleagues from many backgrounds, and invites students from a variety of educational programs to joining our research training environment. Our research program focuses on the development of molecular imaging methods that evaluate the tumor microenvironment, which are used to improve cancer diagnoses and personalized treatment. We aim to develop and apply molecular imaging methods that can predict the outcome of cancer treatment before the treatment is initiated, and can evaluate the early response to treatment that can foreshadow the long-term outcome of the treatment. These outcomes can be used to personalize the treatment regimen, by selecting a more appropriate treatment, or by adjusting the dose amount or dose schedule.  Publications/Creative Works Click here to search for this faculty member's publications on PubMed.  Affiliations  Research Consortia GCC Cluster NanoX Gulf Coast Cluster for Translational Imaging  Appointments Title Department / School Institution Professor and Deputy Chair Cancer Systems Imaging MD Anderson Cancer Center

powering - The Partnership
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.